Application

18767400 · ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY

Filed 2024-07-09 · Pending The official file ↗ · Art unit 1621 · Examiner Kyle Gregory Nottingham Typical · CPC C07D 209/48 · CANCER RESEARCH TECHNOLOGY LIMITED · HESLIN ROTHENBERG FARLEY & MESITI PC

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

19.2 mo

to disposition n/a

Statutes raised

112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.